We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Marken Announces Moscow Depot

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Marken Announces Moscow Depot"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Marken has announced the addition of a dedicated depot in Moscow, Russia. The depot announcement is part of Marken’s ongoing expansion of their global pharmaceutical depot network.

The Russia depot will be located within an existing GxP-compliant storage facility in Moscow, offering a secure and dedicated space near the airport.

The facility will be operated by dedicated staff trained on Marken’s global procedures and managed by the state of the art global inventory system, Solo.

The Solo operating and tracking system provides clients with 24/7 access and monitoring of its global supplies and distribution status.

The announcement follows an exhaustive search for a high-quality fully-operational depot that provides proximity to international airports and shipping lanes.

The new Moscow site is seamlessly integrated into the existing and growing Marken depot network already serving the pharmaceutical industry. It joins Marken’s current network of depots in China, Singapore, Argentina, Mexico, Germany, and the United States.

Marken’s network of pharmaceutical depot facilities and supporting IT systems are designed to provide the most flexible and efficient storage and distribution of materials for the clinical trials community. They are designed for all clinical materials, and are particularly suited for temperature-controlled, time sensitive products which are emerging in most pharmaceutical company pipelines.

Marken has a significant transportation capability in Russia, a country which remains an important clinical trial center. This new depot capability allows the company to expand its portfolio of services in the region.

Gerit Offenhauser, Marken’s Senior Vice President, Clinical Trials Distribution, said, “This co-location in Moscow offers clear market opportunities for our clients who have indicated a need for clinical trial operations in Russia and Eastern Europe. We look forward to meeting the growing needs for depot services in that part of the world.”